Five things to know:
1. Damian Frantz claims that a Sun Pharma supervisor directed him to “aggressively solicit opportunities” to push off-label uses, or those uses that have not been approved by the FDA, of the company’s drugs to physicians and health plan representatives.
2. Mr. Frantz said his supervisor also directed his team “not to put such solicitations in writing, but to make the pitch in person, over the phone or in any untraceable manner.”
3. After he complained several times about the pressure to distribute and push off-label uses of Sun Pharma’s drugs, Mr. Frantz said he was fired.
4. Mr. Franz is seeking damages and to recoup attorneys’ fees.
5. Pharmaceutical companies have urged the FDA to loosen regulations, arguing that they violate free speech rights.
Access the full report here.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
